Alx Oncology Holdings Inc (ALXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -105,687 | -74,980 | -35,581 | -160,805 | -115,333 |
| Depreciation Amortization | -3,066 | -2,306 | -1,275 | -5,401 | -3,791 |
| Accounts payable and accrued liabilities | -637 | -443 | -2,326 | 458 | 4,942 |
| Other Working Capital | -3,670 | -2,348 | -8,558 | 8,297 | 7,966 |
| Other Operating Activity | 23,194 | 15,587 | 9,816 | 27,087 | 15,530 |
| Operating Cash Flow | $-89,866 | $-64,490 | $-37,924 | $-130,364 | $-90,686 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -387 | -238 | -148 | -1,274 | -1,126 |
| Purchase Of Investment | -102,962 | -94,249 | -31,285 | -246,629 | -171,619 |
| Sale Of Investment | 156,422 | 121,867 | 57,906 | 292,560 | 234,068 |
| Investing Cash Flow | $53,073 | $27,380 | $26,473 | $44,657 | $61,323 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -751 | -393 | -175 | -388 | -325 |
| Common Stock Issued | 1,938 | 1,404 | 237 | 59,679 | 450 |
| Other Financing Activity | 29,302 | 29,227 | 3,024 | 0 | 0 |
| Financing Cash Flow | $30,489 | $30,238 | $3,086 | $59,291 | $125 |
| Beginning Cash Position | 22,472 | 22,472 | 22,472 | 48,888 | 48,888 |
| End Cash Position | 16,168 | 15,600 | 14,107 | 22,472 | 19,650 |
| Net Cash Flow | $-6,304 | $-6,872 | $-8,365 | $-26,416 | $-29,238 |
| Free Cash Flow | |||||
| Operating Cash Flow | -89,866 | -64,490 | -37,924 | -130,364 | -90,686 |
| Capital Expenditure | -387 | -238 | -148 | -1,274 | -1,126 |
| Free Cash Flow | -90,253 | -64,728 | -38,072 | -131,638 | -91,812 |